These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25910186)

  • 1. Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis.
    Rossi O; Khan MT; Schwarzer M; Hudcovic T; Srutkova D; Duncan SH; Stolte EH; Kozakova H; Flint HJ; Samsom JN; Harmsen HJ; Wells JM
    PLoS One; 2015; 10(4):e0123013. PubMed ID: 25910186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses.
    Rossi O; van Berkel LA; Chain F; Tanweer Khan M; Taverne N; Sokol H; Duncan SH; Flint HJ; Harmsen HJ; Langella P; Samsom JN; Wells JM
    Sci Rep; 2016 Jan; 6():18507. PubMed ID: 26725514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis.
    Qiu X; Zhang M; Yang X; Hong N; Yu C
    J Crohns Colitis; 2013 Dec; 7(11):e558-68. PubMed ID: 23643066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of live, but not inactivated, Faecalibacterium prausnitzii has a preventive effect on dextran sodium sulfate‑induced colitis in mice.
    Kawade Y; Sakai M; Okamori M; Morita M; Mizushima K; Ueda T; Takagi T; Naito Y; Itoh Y; Shimada T
    Mol Med Rep; 2019 Jul; 20(1):25-32. PubMed ID: 31115531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation.
    Huang XL; Zhang X; Fei XY; Chen ZG; Hao YP; Zhang S; Zhang MM; Yu YQ; Yu CG
    World J Gastroenterol; 2016 Jun; 22(22):5201-10. PubMed ID: 27298563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CCR6 and CXCR6 by Gut-Derived CD4
    Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
    Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.
    Martín R; Chain F; Miquel S; Lu J; Gratadoux JJ; Sokol H; Verdu EF; Bercik P; Bermúdez-Humarán LG; Langella P
    Inflamm Bowel Dis; 2014 Mar; 20(3):417-30. PubMed ID: 24418903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis.
    Carlsson AH; Yakymenko O; Olivier I; Håkansson F; Postma E; Keita AV; Söderholm JD
    Scand J Gastroenterol; 2013 Oct; 48(10):1136-44. PubMed ID: 23971882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
    Sokol H; Pigneur B; Watterlot L; Lakhdari O; Bermúdez-Humarán LG; Gratadoux JJ; Blugeon S; Bridonneau C; Furet JP; Corthier G; Grangette C; Vasquez N; Pochart P; Trugnan G; Thomas G; Blottière HM; Doré J; Marteau P; Seksik P; Langella P
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16731-6. PubMed ID: 18936492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
    Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
    World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Xu B; Fu Y; Yin N; Qin W; Huang Z; Xiao W; Huang H; Mei Q; Fan J; Zeng Y; Huang C
    Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G607-G621. PubMed ID: 38502145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecalibacterium prausnitzii, Bacteroides faecis and Roseburia intestinalis attenuate clinical symptoms of experimental colitis by regulating Treg/Th17 cell balance and intestinal barrier integrity.
    Mohebali N; Weigel M; Hain T; Sütel M; Bull J; Kreikemeyer B; Breitrück A
    Biomed Pharmacother; 2023 Nov; 167():115568. PubMed ID: 37793274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MD-1 deficiency attenuates dextran sodium sulfate (DSS)-induced colitis through modulating the function of colonic lamina propria dendritic cells.
    Pan H; Zhang G; Zhang L; Wang W; Shang J; Wang X; Zhao Q; Li J
    Mol Immunol; 2016 Jul; 75():1-10. PubMed ID: 27209086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protection role of Atg16l1 in CD11c
    Zhang H; Zheng L; Chen J; Fukata M; Ichikawa R; Shih DQ; Zhang X
    Immunobiology; 2017 Jul; 222(7):831-841. PubMed ID: 28390705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
    Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
    Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.
    Miquel S; Leclerc M; Martin R; Chain F; Lenoir M; Raguideau S; Hudault S; Bridonneau C; Northen T; Bowen B; Bermúdez-Humarán LG; Sokol H; Thomas M; Langella P
    mBio; 2015 Apr; 6(2):. PubMed ID: 25900655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.
    Ben-Ami Shor D; Bashi T; Lachnish J; Fridkin M; Bizzaro G; Barshak I; Blank M; Shoenfeld Y
    J Autoimmun; 2015 Jan; 56():111-7. PubMed ID: 25479760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
    Quévrain E; Maubert MA; Michon C; Chain F; Marquant R; Tailhades J; Miquel S; Carlier L; Bermúdez-Humarán LG; Pigneur B; Lequin O; Kharrat P; Thomas G; Rainteau D; Aubry C; Breyner N; Afonso C; Lavielle S; Grill JP; Chassaing G; Chatel JM; Trugnan G; Xavier R; Langella P; Sokol H; Seksik P
    Gut; 2016 Mar; 65(3):415-425. PubMed ID: 26045134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner.
    Srutkova D; Schwarzer M; Hudcovic T; Zakostelska Z; Drab V; Spanova A; Rittich B; Kozakova H; Schabussova I
    PLoS One; 2015; 10(7):e0134050. PubMed ID: 26218526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.